The effects of daily prednisone and tocilizumab on hemoglobin A1c during the treatment of giant cell arteritis.

Naomi J PatelVeronica TozzoJohn M HigginsJohn H Stone

Published in: Arthritis & rheumatology (Hoboken, N.J.) (2022)

Tocilizumab treatment was associated with a substantial reduction in HbA1c, independent of GC exposure, which may be achieved through a combination of glycemic and non-glycemic effects.

Keyphrases

rheumatoid arthritis
type diabetes
giant cell
juvenile idiopathic arthritis
physical activity
metabolic syndrome
mass spectrometry
adipose tissue
combination therapy
red blood cell
gas chromatography
tandem mass spectrometry